We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




AI Automatically Diagnoses Severe Heart Valve Disease from Ultrasound Scans

By HospiMedica International staff writers
Posted on 28 Aug 2023

Severe aortic stenosis, also known as AS, is a common valvular heart disease, especially among older adults, resulting from the narrowing of the aortic valve. More...

Timely identification can enable interventions that alleviate symptoms and mitigate the risk of hospitalization and premature mortality. Doppler echocardiography, a specialized heart ultrasound imaging technique, is the primary test for identifying AS. Now, researchers have developed a deep learning model capable of automatically identifying severe AS using simpler heart ultrasound scans.

The technology, developed by researchers at the Yale School of Medicine (New Haven, CT, USA), was based on 5,257 studies comprising 17,570 videos conducted between 2016 and 2020. The model's accuracy was externally validated using an additional 2,040 consecutive studies from various cohorts. This research facilitates the early detection of AS, enabling patients to receive timely medical attention, and could have implications for routine clinical care.

“Our challenge is that precise evaluation of AS is crucial for patient management and risk reduction,” said Rohan Khera, MD, MS, the study’s senior author. “While specialized testing remains the gold standard, reliance on those who make it to our echocardiographic laboratories likely misses people early in their disease state.”

“Our work can allow broader community screening for AS as handheld ultrasounds can increasingly be used without the need for more specialized equipment. They are already being used frequently in emergency departments, and many other care settings,” added Khera.

Related Links:
Yale School of Medicine 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.